Spared Motivational Modulation of Cognitive Effort in a Maternal Immune Activation Model of Schizophrenia Risk

被引:15
|
作者
Bates, Vanessa [1 ]
Maharjan, Ashim [1 ]
Millar, Jessica [1 ]
Bilkey, David K. [1 ]
Ward, Ryan D. [1 ]
机构
[1] Univ Otago, Dept Psychol, POB 56, Dunedin 9054, New Zealand
关键词
maternal immune activation; signaled reward probability; motivation; schizophrenia; poly I:C; NEURODEVELOPMENTAL ANIMAL-MODEL; NEGATIVE SYMPTOMS; DOPAMINERGIC HYPERFUNCTION; REWARD PROBABILITY; RAT MODEL; DEFICITS; INHIBITION; ETIOLOGY; IMPACT; MICE;
D O I
10.1037/bne0000230
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Maternal immune activation (MIA) during gestation is a significant risk factor for development of schizophrenia and other neurodevelopmental diseases. In animal models of this risk factor, MIA during pregnancy can produce offspring that recapitulate certain aspects of the behavioral and neurophysiological impairments seen in schizophrenia. Here, the authors tested the effect of polyinosinic-polycytidylic acid (poly I:C)-induced MIA in a task that explicitly assays the interaction between motivation and cognition. In our paradigm, discrimination accuracy during a sustained-attention task is differentially impacted by environmental cues that signal the probability of reward for accurate performance. Cognition-motivation interactions are implicated in producing functional impairments in patients. Therefore, to the extent that this MIA model recapitulates such impairments, the authors predicted impaired ability of reward-associated signals to modulate cognitive performance in MIA rat offpsring. Adult offspring of dams in which MIA was induced displayed impaired prepulse inhibition relative to controls, verifying a functional effect of poly I: C induction. Despite this deficit, there were no differences between MIA and control rats in any aspects of task learning or performance, including under extinction and reacquisition conditions. These results indicate that MIA spares functioning of some of the cognitive, motivational, and decision-making processes that are impacted in schizophrenia and suggest that MIA as an isolated manipulation does not model the full range and nuance of the cognitive and motivational impairments in the disease. The authors suggest that some aspects of the functional impairment in schizophrenia and other neurodevelopmental diseases may be better modeled using multiple "hit" models of disease risk.
引用
收藏
页码:66 / 74
页数:9
相关论文
共 50 条
  • [1] Discrimination difficulty, cognitive burden, and reversal impairments in a maternal immune activation model of schizophrenia risk
    Fisken, Rachel
    Ward, Ryan D.
    BEHAVIOURAL PROCESSES, 2019, 167
  • [2] Impaired discrimination of a subanesthetic dose of ketamine in a maternal immune activation model of schizophrenia risk
    Meighan, Wayne
    Elston, Thomas W.
    Bilkey, David
    Ward, Ryan D.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (09) : 1141 - 1151
  • [3] Hippocampal Sequencing Mechanisms Are Disrupted in a Maternal Immune Activation Model of Schizophrenia Risk
    Speers, Lucinda J.
    Cheyne, Kirsten R.
    Cavani, Elena
    Hayward, Tara
    Schmidt, Robert
    Bilkey, David K.
    JOURNAL OF NEUROSCIENCE, 2021, 41 (32) : 6954 - 6965
  • [4] Prenatal infection, maternal immune activation, and risk for schizophrenia
    Canetta, Sarah E.
    Brown, Alan S.
    TRANSLATIONAL NEUROSCIENCE, 2012, 3 (04) : 320 - 327
  • [5] The maternal immune activation model uncovers a role for the Arx gene in GABAergic dysfunction in schizophrenia
    Nakamura, Jay P.
    Schroeder, Anna
    Hudson, Matthew
    Jones, Nigel
    Gillespie, Brendan
    Du, Xin
    Notaras, Michael
    Swaminathan, Vaidy
    Reay, William R.
    Atkins, Joshua R.
    Green, Melissa J.
    Carr, Vaughan J.
    Cairns, Murray J.
    Sundram, Suresh
    Hill, Rachel A.
    BRAIN BEHAVIOR AND IMMUNITY, 2019, 81 : 161 - 171
  • [6] Behavioural deficits associated with maternal immune activation in the rat model of schizophrenia
    Wolff, Amy R.
    Cheyne, Kirsten R.
    Bilkey, David K.
    BEHAVIOURAL BRAIN RESEARCH, 2011, 225 (01) : 382 - 387
  • [7] Vortioxetine improved schizophrenia-like behavioral deficits in a Poly I:C-induced maternal immune activation model of schizophrenia in rats
    Taskiran, Mehmet
    Taskiran, Sacide Yildiz
    Unal, Gokhan
    Bozkurt, Nuh Mehmet
    Golgeli, Asuman
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (06) : 1069 - 1079
  • [8] Paliperidone reverts Toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia
    MacDowell, Karina S.
    Munarriz-Cuezva, Eva
    Caso, Javier R.
    Madrigal, Jose L. M.
    Zabala, Arantzazu
    Meana, J. Javier
    Garcia-Bueno, Borja
    Leza, Juan C.
    NEUROPHARMACOLOGY, 2017, 116 : 196 - 207
  • [9] Reduced cortical somatostatin gene expression in a rat model of maternal immune activation
    Duchatel, Ryan J.
    Harms, Lauren R.
    Meehan, Crystal L.
    Michie, Patricia T.
    Bigland, Mark J.
    Smith, Doug W.
    Jobling, Phillip
    Hodgson, Deborah M.
    Tooney, Paul A.
    PSYCHIATRY RESEARCH, 2019, 282
  • [10] Resveratrol ameliorates the effect of maternal immune activation associated with schizophrenia in adulthood offspring
    Ferreira, Frederico Rogerio
    Barros de Moura, Nathalia Souza
    Hassib, Lucas
    Pombo, Thatiane Rebelo
    NEUROSCIENCE LETTERS, 2020, 734